Lucid Diagnostics Inc. (LUCD) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 5 Buy.
The consensus price target is $2.50 (low: $2.00, high: $3.00), representing an upside of 77.3% from the current price $1.41.
Analysts estimate Earnings Per Share (EPS) of $-0.91 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.05 vs est $-0.91 (missed -15.4%). 2025: actual $-0.69 vs est $-0.58 (missed -20%). Analyst accuracy: 85%.
LUCD Stock — 12-Month Price Forecast
$2.50
▲ +77.30% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Lucid Diagnostics Inc., the average price target is $2.50, with a high forecast of $3.00, and a low forecast of $2.00.
The average price target represents a +77.30% change from the last price of $1.41.
Highest Price Target
$3.00
Average Price Target
$2.50
Lowest Price Target
$2.00
LUCD Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Lucid Diagnostics Inc. in the past 3 months
EPS Estimates — LUCD
85%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.05
vs Est –$0.91
▼ 13.3% off
2025
Actual –$0.69
vs Est –$0.58
▼ 16.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — LUCD
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.005B
▼ 5.1% off
2025
Actual $0.005B
vs Est $0.005B
▲ 3.0% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
